Total Payments
$14,845
2024 Payments
$5,675
Companies
31
Transactions
545
Medicare Patients
4,899
Medicare Billing
$307,229
Payment Breakdown by Category
Food & Beverage$14,501 (97.7%)
Education$343.47 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,501 | 540 | 97.7% |
| Education | $343.47 | 5 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,795 | 103 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,455 | 36 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,117 | 51 | $0 (2024) |
| Amgen Inc. | $1,032 | 28 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $872.17 | 37 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $867.56 | 29 | $0 (2024) |
| Lilly USA, LLC | $821.85 | 28 | $0 (2024) |
| GENZYME CORPORATION | $794.01 | 16 | $0 (2024) |
| PFIZER INC. | $715.22 | 43 | $0 (2024) |
| LEO Pharma Inc. | $632.65 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,675 | 177 | ABBVIE INC. ($1,087) |
| 2023 | $4,644 | 171 | ABBVIE INC. ($868.50) |
| 2022 | $2,374 | 83 | ABBVIE INC. ($516.42) |
| 2021 | $2,152 | 114 | Galderma Laboratories, L.P. ($442.28) |
All Payment Transactions
545 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $1.79 | General |
| 12/17/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $82.11 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $31.57 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.52 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: Inflammation | ||||||
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $179.52 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $93.35 | General |
| Category: Inflammation & Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: DERMATOLOGY | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $35.99 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 931 | 1,680 | $167,332 | $68,367 |
| 2022 | 11 | 803 | 1,255 | $110,333 | $41,977 |
| 2021 | 15 | 1,658 | 3,416 | $265,184 | $106,419 |
| 2020 | 11 | 1,507 | 2,953 | $262,404 | $90,465 |
Total Patients
4,899
Total Services
9,304
Medicare Billing
$307,229
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 185 | 288 | $54,376 | $22,785 | 41.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 199 | 199 | $48,901 | $20,412 | 41.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 156 | 192 | $19,247 | $6,981 | 36.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 64 | 76 | $11,580 | $4,830 | 41.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 118 | 670 | $6,727 | $2,821 | 41.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 24 | 25 | $6,282 | $2,676 | 42.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 58 | 71 | $5,887 | $2,372 | 40.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 39 | 39 | $4,148 | $1,730 | 41.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 23 | 25 | $4,205 | $1,536 | 36.5% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 18 | 30 | $2,547 | $979.19 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 15 | $2,000 | $670.37 | 33.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 13 | 18 | $1,355 | $551.71 | 40.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 19 | 32 | $77.96 | $25.61 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 117 | 139 | $23,096 | $10,082 | 43.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 85 | 85 | $18,123 | $9,088 | 50.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 144 | 148 | $17,322 | $4,973 | 28.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 139 | 151 | $16,964 | $4,559 | 26.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 74 | 74 | $12,078 | $4,091 | 33.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 24 | 30 | $4,682 | $1,995 | 42.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 64 | 71 | $4,962 | $1,950 | 39.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 109 | 508 | $5,019 | $1,932 | 38.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 15 | 17 | $4,248 | $1,627 | 38.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $2,202 | $879.63 | 39.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 17 | 17 | $1,637 | $799.55 | 48.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 381 | 509 | $58,072 | $27,357 | 47.1% |
About Julie Johnson, PA-C
Julie Johnson, PA-C is a Physician Assistant healthcare provider based in Ashburn, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1568512465.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Julie Johnson, PA-C has received a total of $14,845 in payments from pharmaceutical and medical device companies, with $5,675 received in 2024. These payments were reported across 545 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($14,501).
As a Medicare-enrolled provider, Johnson has provided services to 4,899 Medicare beneficiaries, totaling 9,304 services with total Medicare billing of $307,229. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Ashburn, VA
- Active Since 01/11/2007
- Last Updated 03/17/2015
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1568512465
Products in Payments
- DUPIXENT (Biological) $2,287
- RINVOQ (Biological) $1,484
- SKYRIZI (Biological) $988.97
- Otezla (Drug) $765.04
- ADBRY (Biological) $603.22
- TREMFYA (Drug) $598.27
- COSENTYX (Drug) $583.85
- EUCRISA (Drug) $530.32
- AKLIEF (Drug) $528.72
- OPZELURA (Drug) $501.70
- VTAMA (Drug) $360.92
- Bimzelx (Biological) $342.05
- HUMIRA (Biological) $303.15
- TALTZ (Drug) $294.81
- OLUMIANT (Drug) $291.23
- Winlevi (Drug) $279.50
- Enbrel (Biological) $266.53
- ILUMYA (Biological) $227.56
- Zoryve (Drug) $195.50
- Sotyktu (Drug) $180.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Ashburn
Taylor Rehfuss, Pa-C, PA-C
Physician Assistant — Payments: $12,531
Physician Assistant $12,531
Mrs. Garry Jelen, P.a.-C, P.A.-C
Physician Assistant — Payments: $4,450
Physician Assistant $4,450
Annie Pratt, Pa-C, PA-C
Physician Assistant — Payments: $4,170
Physician Assistant $4,170
Ms. Melissa Walker, Pa-C, PA-C
Physician Assistant — Payments: $1,597
Physician Assistant $1,597
Meredith West, Pa-C, PA-C
Physician Assistant — Payments: $1,233
Physician Assistant $1,233
Jessica Myslikowski
Physician Assistant — Payments: $826.16
Physician Assistant $826.16